Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan/Naproxen Combination vs Components on Blood Pressure in Migraine
NCT00792636Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sumatriptan + naproxen sodium in migraine (3 arms), sponsored by GSK. Primary endpoint: Mean Change From Baseline in Systolic and Diastolic Blood Pressure at Month 6. Started Nov 2008; status: completed.
02
Drugs
sumatriptan + naproxen sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00792636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792636.